Advancements in Therapeutics and Rising Disease Prevalence Drive Market Expansion The Polycythemia Vera (PV) treatment market Growth is experiencing significant growth, with projections estimating an increase from USD 5.90 billion in 2023 to USD 11.36 billion by 2030, reflecting a robust compound annual growth rate (CAGR) of 9.8%. This upward trajectory underscores the escalating...